{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:06:08Z","timestamp":1770509168788,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.transproceed.2018.03.083","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T17:41:53Z","timestamp":1521481313000},"page":"2565-2568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report"],"prefix":"10.1016","volume":"50","author":[{"given":"A.","family":"Ishiwatari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.03.083_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","article-title":"Membranous nephropathy: a journey from bench to bedside","volume":"68","author":"Francis","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2018.03.083_bib2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1600-6143.2008.02237.x","article-title":"Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study","volume":"8","author":"Dabade","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.083_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A\u00a0proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.083_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.03.083_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00007890-199505150-00009","article-title":"Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients","volume":"59","author":"Couchoud","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.03.083_bib6","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1097\/TP.0000000000001056","article-title":"Recurrent membranous nephropathy after kidney transplantation: treatment and long-term implications","volume":"10","author":"Grupper","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.03.083_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1600-6143.2011.03903.x","article-title":"The pathology and clinical features of early recurrent membranous glomerulonephritis","volume":"12","author":"Rodriguez","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.083_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ki.1980.62","article-title":"Control of complement activation in membranous and membranoproliferative glomerulonephritis","volume":"17","author":"Moseley","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.03.083_bib9","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1111\/j.1600-6143.2009.02851.x","article-title":"Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.083_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2017.92","article-title":"Treatment of membranous nephropathy: time for a paradigm shift","volume":"13","author":"Ruggenenti","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.083_bib11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518304160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518304160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T05:24:09Z","timestamp":1539235449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518304160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0041134518304160"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.03.083","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.03.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}